ARTICLE | Clinical News
Eylea aflibercept ophthalmic solution regulatory update
November 9, 2015 8:00 AM UTC
The European Commission approved Eylea aflibercept from Bayer to treat visual impairment due to myopic choroidal neovascularization (CNV). Eylea is approved in the EU to treat wet age-related macular ...